Zoetis has appointed Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs at Johnson & Johnson to its Board of Directors.
Broadhurst’s appointment will see the board grow from 11 to 12 members, and she will serve on the Board’s Quality and Innovation Committee.
Kristin Peck, CEO of Zoetis, said that Broadhurst brings invaluable experience to its Board.
“Along with a deep understanding of the global pharmaceutical industry, she is widely respected for her strategic insight and leadership, as well as her expertise in consumer healthcare marketing and digital communications. She will be a tremendous addition to our Board.”
Broadhurst is currently a member of Johnson & Johnson’s Executive Committee and leads the company’s global marketing, communication, design, and philanthropy functions, in addition to having oversight of Johnson & Johnson Health and Wellness Solutions.
Broadhurst has previously been recognised as ‘Healthcare Champion of the Year’ by the National Association for Female Executives, and was named one of the ‘2022 Most Influential Black Executives in Corporate America’ by SAVOY magazine.
As well as her new appointment to the Zoetis Board of Directors, Broadhurst serves as a member of The Executive Leadership Council (ELC), a preeminent association of black business leaders, and is also a board member of the Ad Council, an American non-profit organisation.
Michael McCallister, Chairman of Zoetis, said they are all very pleased to welcome Broadhurst to the Board of Directors.
“I am very proud of the calibre of all our Board members, and we look forward to all the contributions Vanessa will make to Zoetis as we continue to nurture the world and humankind by advancing care for animals.”